# MDD-platform-trials
 Performs simulations for platform trials in the field of major depressive disorders



## Disclaimer

EU-PEARL (EU Patient-cEntric clinicAl tRial pLatforms) project has
received funding from the Innovative Medicines Initiative (IMI) 2 Joint
Undertaking (JU) under grant agreement No 853966. This Joint Undertaking
receives support from the European Union’s Horizon 2020 research and
innovation program and EFPIA and Children’s Tumor Foundation, Global
Alliance for TB Drug Development non-profit organization, Springworks
Therapeutics Inc. This publication reflects the authors’ views. Neither
IMI nor the European Union, EFPIA, or any Associated Partners are
responsible for any use that may be made of the information contained
herein. The research of Elias Laurin Meyer was funded until 11/2020 by
Novartis through the University and not at an individual level.
